Serum levels of anti–T-Ag antibodies have additionally served as an indicator of disease burden (12), and T-Ag–reactive CD8+ T cells are exclusively detected in MCC patients with virus-positive tumors compared with healthy donors and MCC patients with virus-negative tumors (13, 14). The gene discussed is CD8A; the disease is Merkel cell skin cancer.